Vasilios J. Kalogredis, left, and Rachel E. Lusk Klebanoff, right, of Lamb McErlane. Vasilios J. Kalogredis, left, and Rachel E. Lusk Klebanoff, right, of Lamb McErlane.

On April 28, the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services issued an advisory opinion (No. 22-09) declining to approve a laboratory company's proposal to pay hospitals a fair market value, per-patient-encounter fee to collect, process and handle specimens.